Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intra-alveolar Adhesive Biomaterial Preserves Ridge Height After Tooth Extraction in Dogs.

Journal of the American Animal Hospital Association·2026
Same author

Multiparametric MRI in prostate cancer active surveillance: results from the Miami Active Surveillance Trial (MAST) trial.

BJU international·2026
Same author

Evaluating MRI findings and biopsy strategies to maximize detection of grade progression in men on active surveillance for prostate cancer.

Urologic oncology·2026
Same author

mpMRI-Based Risk Estimation to Optimize Prostate Cancer Patient Selection for Active Surveillance.

Cancers·2026
Same author

Hormone therapy use and duration with postoperative radiotherapy for recurrent prostate cancer: an individual patient data meta-analysis.

Lancet (London, England)·2026
Same author

Prediction Analysis of Microarray of 50 genes (PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami Active Surveillance Trial (MAST).

BJU international·2026

Related Experiment Video

Updated: Jul 9, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Postprostatectomy radiation therapy for prostate cancer.

Matthew C Abramowitz1, Alan Pollack

  • 1Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.

Seminars in Radiation Oncology
|December 18, 2007
PubMed
Summary
This summary is machine-generated.

Adjuvant radiotherapy after radical prostatectomy significantly reduces biochemical failure in high-risk prostate cancer patients. This treatment is recommended due to its low morbidity and proven efficacy in recent trials.

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Related Experiment Videos

Last Updated: Jul 9, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Area of Science:

  • Oncology
  • Urology
  • Radiation Oncology

Background:

  • Radical prostatectomy is a primary treatment for prostate cancer.
  • High-risk features like positive margins increase recurrence risk.
  • Adjuvant and salvage radiotherapy are used post-prostatectomy.

Purpose of the Study:

  • To evaluate the role of adjuvant radiotherapy in managing high-risk prostate cancer post-radical prostatectomy.
  • To discuss the optimal timing of radiotherapy administration.
  • To assess the benefits of adjuvant radiotherapy versus radical prostatectomy alone.

Main Methods:

  • Review of recent randomized trials comparing adjuvant radiotherapy with radical prostatectomy alone.
  • Analysis of outcomes related to biochemical failure.
  • Consideration of treatment morbidity and patient risk factors.

Main Results:

  • Three recent randomized trials consistently show improved biochemical failure rates with adjuvant radiotherapy.
  • Adjuvant radiotherapy demonstrates a significant benefit compared to radical prostatectomy alone.
  • Postoperative radiotherapy has relatively low associated morbidity.

Conclusions:

  • Adjuvant radiotherapy should be strongly considered for patients with high-risk pathologic features after radical prostatectomy.
  • The evidence supports improved outcomes with adjuvant radiotherapy in this patient group.
  • Further research is needed to clarify the role of androgen deprivation post-prostatectomy.